Extensive study identifies over a dozen existing drugs as potential COVID-19 therapies
E-Mail IMAGE: A researcher at Calibr, the drug discovery division of Scripps Research, working in the high-throughput screening facility used to identify potential COVID-19 therapies. view more Credit: Scripps Research June 3, 2021 - LA JOLLA, CA--Mining the world's most comprehensive drug repurposing collection for COVID-19 therapies, scientists have identified 90 existing drugs or drug candidates with antiviral activity against the coronavirus that's driving the ongoing global pandemic. Among those compounds, the Scripps Research study identified four clinically approved drugs a...